OC
CNCR

Oppenheimer & Co’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Oppenheimer & Co’s Portfolio CNCR Stock Details CNCR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
2019
Q1 		$215K Sell
2018
Q4 		$193K Buy
2018
Q3 		$201K Buy